P. Joly

A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid

P. Joly, Jean‐Claude Roujeau, Jacques Bénichou et al. · New England Journal of Medicine · 2002 · 614 citations

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 586 citations

Ritux 3, Pharmacology, Pharmacotherapy +2

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Dédée F. Murrell, Sarah Dick, A. R. Ahmed et al. · Journal of the American Academy of Dermatology · 2008 · 575 citations · Full text

Pathogenesis, Immunology, Therapeutic Response +3

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 460 citations

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response

D Picard, Baptiste Janela, V. Descamps et al. · Science Translational Medicine · 2010 · 382 citations